Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants

IMPORTANCE: The clinical importance of genetic testing of BRCA1 and BRCA2 in breast, ovarian, prostate, and pancreatic cancers is widely recognized. However, there is insufficient evidence to include other cancer types that are potentially associated with BRCA1 and BRCA2 in clinical management guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Momozawa, Yukihide, Sasai, Rumi, Usui, Yoshiaki, Shiraishi, Kouya, Iwasaki, Yusuke, Taniyama, Yukari, Parsons, Michael T., Mizukami, Keijiro, Sekine, Yuya, Hirata, Makoto, Kamatani, Yoichiro, Endo, Mikiko, Inai, Chihiro, Takata, Sadaaki, Ito, Hidemi, Kohno, Takashi, Matsuda, Koichi, Nakamura, Seigo, Sugano, Kokichi, Yoshida, Teruhiko, Nakagawa, Hidewaki, Matsuo, Keitaro, Murakami, Yoshinori, Spurdle, Amanda B., Kubo, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011177/
https://www.ncbi.nlm.nih.gov/pubmed/35420638
http://dx.doi.org/10.1001/jamaoncol.2022.0476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011177/
https://www.ncbi.nlm.nih.gov/pubmed/35420638
http://dx.doi.org/10.1001/jamaoncol.2022.0476

Ejemplares similares